Found 526 results
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
van Vugt, M. et al. Absence of an interaction between artesunate and atovaquone-proguanil. European Journal of Clinical Pharmacology 55, 469-74 (1999).
Gaillard, T. et al. Absence of association between Plasmodium falciparum small sub-unit ribosomal RNA gene mutations and in vitro decreased susceptibility to doxycycline. Malaria Journal 14, 348 (2015).
Kuile, F. O. Ter et al. Absorption of intramuscular phenobarbitone in children with severe falciparum malaria. European Journal of Clinical Pharmacology 42, 107-10 (1992).
White, A. L. et al. Accelerated Training of Skilled Birth Attendants in a Marginalized Population on the Thai-Myanmar Border: A Multiple Methods Program Evaluation. PLoS One 11, e0164363 (2016).
Kajeechiwa, L. et al. The acceptability of mass administrations of anti-malarial drugs as part of targeted malaria elimination in villages along the Thai-Myanmar border. Malar J 15, 494 (2016).
Tschirhart, N. , Nosten, F. & Foster, A. M. . Access to free or low-cost tuberculosis treatment for migrants and refugees along the Thailand-Myanmar border in Tak province, Thailand. International Journal for Equity in Health 15, 1 (2016).
McGready, R. , Kaveri, S. V. , Lacroix-Desmazes, S. , Krudsood, S. & Newton, P. N. . Acquired haemophilia A in early pregnancy associated with Plasmodium vivax malaria and hyperthyroidism. Aust N Z J Obstet Gynaecol 47, 76-7 (2007).
Nair, S. et al. Adaptive copy number evolution in malaria parasites. PLOS GENET 4, e1000243 (2008).
White, N. J. & Nosten, F. . Advances in chemotherapy and prophylaxis of malaria. Current Opinion in Infectious Diseases 6, 323-330 (1993).
Price, R. et al. Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives. American Journal of Tropical Medicine and Hygiene 60, 547-55 (1999).
McGready, R. et al. Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study. Lancet Infect Dis 12, 388-396 (2012).
Poespoprodjo, J. R. et al. Adverse pregnancy outcomes in an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum infections are endemic. Clin Infect Dis 46, 1374-81 (2008).
Turner, P. et al. Aeromonas spp. Bacteremia in Pregnant Women, Thailand-Myanmar Border, 2011. Emerg Infect Dis 18, 1522-3 (2012).
Suwanarusk, R. et al. Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivax. J Infect Dis 198, 1558-64 (2008).
Manske, M. et al. Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing. NATURE 487, 375-9 (2012).
Pratt, B. et al. Ancillary Care: From Theory to Practice in International Clinical Research. Public Health Ethics 6, 154-169 (2013).
McLean, A. R. et al. Antibody responses to Plasmodium falciparum and Plasmodium vivax blood-stage and sporozoite antigens in the postpartum period. Sci Rep 6, 32159 (2016).
Herbert, J. et al. Antibody-mediated complement C3b/iC3b binding to group B Streptococcus in paired mother and baby serum samples in a refugee population on the Thailand-Myanmar border. Clin Vaccine Immunol 22, 319-26 (2015).
Bitencourt, A. R. et al. Antigenicity and immunogenicity of Plasmodium vivax merozoite surface protein-3. PLoS ONE 8, e56061 (2013).
Phyo, A. Pyae et al. Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial. Lancet Infect Dis (2015). doi:10.1016/S1473-3099(15)00320-5
Phyo, A. Pyae et al. Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial. The Lancet Infectious Diseases 16, 61-69 (2016).
Ward, S. A. , Sevene, E. J. , Hastings, I. M. , Nosten, F. & McGready, R. . Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilance. Lancet Infect Dis 7, 136-44 (2007).
Nosten, F. et al. Antimalarial drugs in pregnancy: a review. Current Drug Safety 1, 1-16 (2006).
Checchi, F. et al. Antimalarial efficacy of sulfadoxine-pyrimethamine, amodiaquine and a combination of chloroquine plus sulfadoxine-pyrimethamine in Bundi Bugyo, western Uganda. Trop Med Int Health 9, 445-50 (2004).
Biot, C. et al. The antimalarial ferroquine: from bench to clinic. Parasite 18, 207-14 (2011).




Shoklo Malaria Research Unit
68/30 Bantung Road, PO Box 46
Mae Sot, Tak 63110 Thailand

Tel: +66 (0) 55 532 026
       +66 (0) 55 532 028
Fax: +66 (0) 55 532 027
Email SMRU

Zircon - This is a contributing Drupal Theme
Design by WeebPal.